Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-009275
Filing Date
2024-12-02
Accepted
2024-12-02 16:06:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4066
  Complete submission text file 0001950047-24-009275.txt   5808
Mailing Address C/O TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY, SUITE 490 MORRISVILLE NC 27560
Business Address
RALLIS CHRIS A (Reporting) CIK: 0001185945 (see all company filings)

Type: 144

Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-32295 | Film No.: 241519053
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)